You are currently viewing Coronavirus vaccine results will be known on November 25: Modern CEO
Coronavirus vaccine results will be known on November 25 Modern CEO

Coronavirus vaccine results will be known on November 25: Modern CEO

As coronavirus infections are on the rise around the world, there is a growing demand for vaccine test results. Clinical trials of more than 30 vaccines are underway around the world. Some of these vaccines are in the third or final stage of testing.

[icegram campaigns="2449"]

Discussions are underway around the world about the modern vaccine in the United States, which is in the third stage of vaccination testing. The U.S. biotechnology company will seek approval from the U.S. Food and Drug Administration (FDA) for the emergency use of their vaccines after November 25, according to a report in the U.S. magazine Forbes.

The modern MRNA-1263 vaccine must be proven to be safe enough before it can be approved. Permitted for emergency use by the FDA, it can be used for emergency health needs.

Stephen Bansal, CEO of Modern, said: Then we can apply for the emergency use of the vaccine. ‘

Bansal, however, said he did not expect their vaccine to be approved before the end of the first quarter or the first quarter of next year. According to FDA policy, at least half of the volunteers taking part in the test must be monitored for two months after the last vaccination to obtain emergency approval for vaccine use.

“Depending on what we know about the vaccine, it may be time to approve it at the end of the first trimester or at the beginning of the second trimester,” Bansal said.

The first phase of the study found that the vaccine may be effective in the elderly.
As an early-stage test of the vaccine, the first step was to show tolerance and resistance in the elderly. The research article was published in the New England Journal of Medicine.

Tal Jacques, chief medical officer of Modern, said the data, obtained in the first phase of the study, showed hope that the vaccine could be effective in the elderly. This can be reviewed in the third step test.

Side effects of the modern vaccine test are also being discussed. According to Modern, the side effects of their vaccine are mild to moderate. Modern has so far vaccinated 15,000 to 30,000 participants and their vaccinations are in the middle stages of testing.

Bansal admits Pfizer is a little ahead of them in vaccination testing. They got this benefit as they took a short break between the two-step vaccination tests. Pfizer, a US vaccine manufacturer, is in the final stages of testing.

So far no vaccine or antiviral treatment has been approved to prevent Covid-19. Corona infections have killed more than one million people worldwide.

Choloman Sangbad

I'm an editor in chief of Choloman Sangbad. Stay Connected with cholomansangbad

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.